Exhibit 31.2

CERTIFICATION

I, Wenjun Jiao, certify that:

     1. I have reviewed this Annual Report on Form 10-KSB of Tiens Biotech Group
(USA), Inc.;

     2. Based on my  knowledge,  this Annual  Report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial condition,  results of operations and cash flows of the small business
issuer as of, and for, the periods presented in this report;

     4.  The  small  business  issuer's  other  certifying  officers  and  I are
responsible for establishing and maintaining  disclosure controls and procedures
(as  defined  in  Exchange  Act Rules  13a-15(e)  and  15d-15(e))  for the small
business issuer and have:

          (a) designed such disclosure  controls and procedures,  or caused such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure  that  material  information  relating  to  the  small  business  issuer,
including its  consolidated  subsidiaries,  is made known to us by others within
those  entities,  particularly  during the period in which this  report is being
prepared;

          (b)  evaluated  the  effectiveness  of  the  small  business  issuer's
disclosure  controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

          (c) disclosed in this report any change in the small business issuer's
internal  control  over  financial  reporting  that  occurred  during  the small
business  issuer's  fourth fiscal  quarter that has materially  affected,  or is
reasonably  likely to materially  affect,  the small business  issuer's internal
control over financial reporting; and

     5.  The  small  business  issuer's  other  certifying  officers  and I have
disclosed,  based  on our  most  recent  evaluation  of  internal  control  over
financial  reporting,  to the small  business  issuer's  auditors  and the audit
committee  of the  small  business  issuer's  board  of  directors  (or  persons
performing the equivalent functions):

          (a) all significant deficiencies and material weaknesses in the design
or operation of internal  control over financial  reporting which are reasonably
likely to  adversely  affect  the small  business  issuer `s  ability to record,
process, summarize and report financial information; and

          (b) any fraud,  whether or not material,  that involves  management or
other  employees who have a  significant  role in the small  business  issuer `s
internal controls over financial reporting.



Dated: March 31, 2005                               /s/ Wenjun Jiao
                                                   -----------------------------
                                                   Wenjun Jiao
                                                   Chief Financial Officer,
                                                   (Principal Financial Officer)